IL-10 is critically involved in mycobacterial HSP70 induced suppression of proteoglycan-induced arthritis

PLoS ONE

Volumn 4, Issue 1, 2009, Pages

  Wieten, Lotte ^a   Berlo, Suzanne E ^a   ten Brink, Corlinda B ^a   van Kooten, Peter J ^a   Singh, Mahavir ^b   van der Zee, Ruurd ^a   Glant, Tibor T ^c   Broere, Femke ^a  

^a Department of Infectious Diseases and Immunology   (Netherlands)

^b LIONEX DIAGNOSTICS AND THERAPEUTICS GMBH   (Germany)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HEAT SHOCK PROTEIN 70; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 10; MESSENGER RNA; PROTEOGLYCAN; RECOMBINANT HEAT SHOCK PROTEIN 70; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; FEMALE; GENE EXPRESSION; IMMUNIZATION; IMMUNOREGULATION; IN VITRO STUDY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; REGULATORY T LYMPHOCYTE; VACCINATION; ANIMAL; CHEMICALLY INDUCED DISORDER; CHEMISTRY; IMMUNOLOGY; INFLAMMATION; MYCOBACTERIUM; PHYSIOLOGY; T LYMPHOCYTE;

ANIMALIA; MURINAE; MUS;

ANIMALS; ARTHRITIS, EXPERIMENTAL; HSP70 HEAT-SHOCK PROTEINS; IMMUNIZATION; INFLAMMATION; INTERLEUKIN-10; MICE; MYCOBACTERIACEAE; PROTEOGLYCANS; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 58449116889     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004186     Document Type: Article

References (40)

1. van Eden W, van der Zee R, Prakken B (2005) Heat-shock proteins induce T-cell regulation of chronic inflammation. Nat Rev Immunol 5(4): 318-330.
2. van Eden W,Wick G, Albani S, Cohen I (2007) Stress, Heat Shock Proteins, and Autoimmunity: How immune responses to heat shock proteins are to be used for the control of chronic inflammatory diseases. Ann N Y Acad Sci 113: 217-237.
3. Bockova J, Elias D, Cohen IR (1997) Treatment of NOD diabetes with a novel peptide of the hsp60 molecule induces Th2-type antibodies. J Autoimmun 10(4): 323-329.
4. van Puijvelde GH, van Es T, van Wanrooij EJ, Habets KL, de Vos P, et al. (2007) Induction of Oral Tolerance to HSP60 or an HSP60-Peptide Activates T Cell Regulation and Reduces Atherosclerosis. Arterioscler Thromb Vasc Biol 27: 2677-2683.
5. de Kleer IM, Kamphuis SM, Rijkers GT, Scholtens L, Gordon G, et al. (2003) The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30+ T cells directed to human heat-shock protein 60 capable of producing the regulatory cytokine interleukin-10. Arthritis Rheum 48(7): 2001-2010.
6. Kamphuis S, Kuis W, de Jager W, Teklenburg G, Massa M, et al. (2005) Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis. Lancet 366(9479): 50-56.
7. Prakken BJ, Wendling U, van der Zee R, Rutten VP, Kuis W, et al. (2001) Induction of IL-10 and inhibition of experimental arthritis are specific features of microbial heat shock proteins that are absent for other evolutionarily conserved immunodominant proteins. J Immunol 167(8): 4147-4153.
8. van der Zee R, Anderton SM, Prakken AB, Liesbeth Paul AG, et al. (1998) T cell responses to conserved bacterial heat-shock-protein epitopes induce resistance in experimental autoimmunity. Semin Immunol 10(1): 35-41.
9. Wendling U, Paul L, van der Zee R, Prakken B, Singh M, et al. (2000) A conserved mycobacterial heat shock protein (hsp) 70 sequence prevents adjuvant arthritis upon nasal administration and induces IL-10-producing T cells that cross-react with the mammalian self-hsp70 homologue. J Immunol 164(5): 2711-2717.
10. Tanaka S, Kimura Y, Mitani A, Yamamoto G, Nishimura H, et al. (1999) Activation of T cells recognizing an epitope of heat-shock protein 70 can protect against rat adjuvant arthritis. J Immunol 163(10): 5560-5565.
11. Prakken BJ, Samodal R, Le TD, Giannoni F, Yung GP, et al. (2004) Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis. Proc Natl Acad Sci U S A 101(12): 4228-4233.
12. Raz I, Elias D, Avron A, Tamir M, Metzger M, et al. (2001) Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial. Lancet 358(9295): 1749-1753.
13. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19: 683-765.
14. van Roon JA, van Roy JL, Gmelig-Meyling FH, Lafeber FP, Bijlsma JW (1996) Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4. Arthritis Rheum 39(5): 829-835.
15. Katsikis PD, Chu CQ, Brennan FM, Maini RN, Feldmann M (1994) Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 179(5): 1517-1527.
16. Tang Q, Bluestone JA (2005) The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol 9(3): 239-244.
17. Glant TT, Finnegan A, Mikecz K (2003) Proteoglycan-induced arthritis: immune regulation, cellular mechanisms, and genetics. Crit Rev Immunol 23(3): 199-250.
18. Hanyecz A, Berlo SE, Szanto S, Broeren CP, Mikecz K, et al. (2004) Achievement of a synergistic adjuvant effect on arthritis induction by activation of innate immunity and forcing the immune response toward the Th1 phenotype. Arthritis Rheum 50(5): 1665-1676.
19. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75(2): 263-274.
20. Berlo SE, Guichelaar T, Ten Brink CB, van Kooten PJ, Hauet-Broeren F, et al. (2006) Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice. Arthritis Rheum 54(8): 2423-2433.
21. Kim HR, Kim EY, Cerny J, Moudgil KD (2006) Antibody responses to mycobacterial and self heat shock protein 65 in autoimmune arthritis: epitope specificity and implication in pathogenesis. J Immunol 177(10): 6634-6641.
22. Ulmansky R, Cohen CJ, Szafer F, Moallem E, Fridlender ZG, et al. (2002) Resistance to adjuvant arthritis is due to protective antibodies against heat shock protein surface epitopes and the induction of IL-10 secretion. J Immunol 168(12): 6463-6469.
23. Albani S, Keystone EC, Nelson JL, Ollier WE, La Cava A, et al. (1995) Positive selection in autoimmunity: abnormal immune responses to a bacterial dnaJ antigenic determinant in patients with early rheumatoid arthritis. Nat Med 1(5): 448-452.
24. Van Eden W, Waksman BH (2003) Immune regulation in adjuvant-induced arthritis: possible implications for innovative therapeutic strategies in arthritis. Arthritis Rheum 48(7): 1788-1796.
25. Kingston AE, Hicks CA, Colston MJ, Billingham ME (1996) A 71-kD heat shock protein (hsp) from Mycobacterium tuberculosis has modulatory effects on experimental rat arthritis. Clin Exp Immunol 103(1): 77-82.
26. Quintana FJ, Carmi P, Mor F, Cohen IR (2004) Inhibition of adjuvant-induced arthritis by DNA vaccination with the 70-kd or the 90-kd human heat-shock protein: immune cross-regulation with the 60-kd heat-shock protein. Arthritis Rheum 50(11): 3712-3720.
27. Glant TT, Mikecz K (2004) Proteoglycan aggrecan-induced arthritis: a murine autoimmune model of rheumatoid arthritis. Methods Mol Med 102: 313-338.
28. Haug M, Dannecker L, Schepp CP, Kwok WW, Wernet D, et al. (2005) The heat shock protein Hsp70 enhances antigen-specific proliferation of human CD4+ memory T cells. Eur J Immunol 35(11): 3163-3172.
29. Mekala DJ, Alli RS, Geiger TL (2005) IL-10-dependent infectious tolerance after the treatment of experimental allergic encephalomyelitis with redirected CD4+CD25+ T lymphocytes. Proc Natl Acad Sci U S A 102(33): 11817-11822.
30. Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, et al. (2006) Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 212: 28-50.
31. Roncarolo MG, Gregori S (2008) Is FOXP3 a bona fide marker for human regulatory T cells? Eur J Immunol 38(4): 925-927.
32. Edwards JC, Cambridge G (2006) B-cell targeting in rheumatoid arthritis and other autoimmune diseases. Nat Rev Immunol 6(5): 394-403.
33. O'Neill SK, Shlomchik MJ, Glant TT, Cao Y, Doodes PD, et al. (2005) Antigen-specific B cells are required as APCs and autoantibody-producing cells for induction of severe autoimmune arthritis. J Immunol 174(6): 3781-3788.
34. Kaplan C, Valdez JC, Chandrasekaran R, Eibel H, Mikecz K, et al. (2002) Th1 and Th2 cytokines regulate proteoglycan-specific autoantibody isotypes and arthritis. Arthritis Res 4(1): 54-58.
35. Guichelaar T, Ten Brink CB, van Kooten PJ, Berlo SE, Broeren CP, et al. (2008) Autoantigen-specific IL-10-transduced T cells suppress chronic arthritis by promoting the endogenous regulatory IL-10 response. J Immunol 180(3): 1373-1381.
36. Verhoef CM, van Roon JA, Vianen ME, Bijlsma JW, Lafeber FP (2001) Interleukin 10 (IL-10), not IL-4 or interferon-gamma production, correlates with progression of joint destruction in rheumatoid arthritis. J Rheumatol 28(9): 1960-1966.
37. De Graeff-Meeder ER, van der Zee R, Rijkers GT, Schuurman HJ, Kuis W, et al. (1991) Recognition of human 60 kD heat shock protein by mononuclear cells from patients with juvenile chronic arthritis. Lancet 337(8754): 1368-1372.
38. Schett G, Redlich K, Xu Q, Bizan P, Groger M, et al. (1998) Enhanced expression of heat shock protein 70 (hsp70) and heat shock factor 1 (HSF1) activation in rheumatoid arthritis synovial tissue. Differential regulation of hsp70 expression and hsf1 activation in synovial fibroblasts by proinflammatory cytokines, shear stress, and antiinflammatory drugs. J Clin Invest 102(2): 302-311.
39. Boog CJ, de Graeff-Meeder ER, Lucassen MA, van der Zee R, Voorhorst-Ogink MM, et al. (1992) Two monoclonal antibodies generated against human hsp60 show reactivity with synovial membranes of patients with juvenile chronic arthritis. J Exp Med 175(6): 1805-1810.
40. Corrigall VM, Bodman-Smith MD, Fife MS, Canas B, Myers LK, et al. (2001) The human endoplasmic reticulum molecular chaperone BiP is an autoantigen for rheumatoid arthritis and prevents the induction of experimental arthritis. J Immunol 166(3): 1492-1498.